Pulmicort®

INHALED CORTICOSTEROIDS

INHALED CORTICOSTEROID (ICS)

  • Class

    • Inhaled corticosteroid (ICS)

  • Active ingredient

    • Budesonide

  • Device

  • Age

    • 6 +
  • Typical use

    • Asthma
      Initial controller

    Asthma management principles
    • COPD (off-label)
      in addition to a dual bronchodilation (LAMA/LABA) when exacerbating

    COPD management principles
  • Marketed strength

    • 100 mcg
    • 200 mcg
    • 400 mcg
  • Number of doses

    • 200 doses
  • Dose indicator

    • Yes | Indicator
  • Usual adult dosage

    • Low | 200 mcg – 1 inh BID
      Medium | 400 mcg – 1 inh BID
      High | 400 mcg – 2 inh BID
      Maximum daily dose: 2400 mcg

    ICS dosing
  • Usual pediatric dosage

    • 6-11 years
      Low
      | 100 mcg – 1 inh BID
      Medium | 200 mcg – 1 inh BID

       

      12-17 years
      See adult dosage

    ICS dosing
  • Required inspiratory flow

    • > 30 - 60 L/min
      Medium-high internal resistance (R4)

    Inspiratory flows
  • Public coverage

    • All provinces | Open/Regular Benefit

  • Advantages

    • Only powder without lactose
  • Disadvantages

    • BID dosing
    • Unprecise dose counter
    Side effects

Product monograph

Download

Search for other inhalers